克洛弗健康投资公司第四季度每股收益$(0.04)优于预期$(0.07),销售额$3.3696亿低于预期$3.8255亿

财报速递2025-02-28
克洛弗健康投资公司(NASDAQ:CLOV)报告季度每股亏损$(0.04),比分析师预期的$(0.07)高42.86%。 这比去年同期每股亏损$(0.14)增加了71.43%。公司报告季度销售额为$3.3696亿,低于分析师预期$3.8255亿,低11.92%。这比去年同期的$3.1238亿销售额增长了7.87%。

以上内容来自Benzinga Earnings专栏,原文如下:

Clover Health Investments (NASDAQ:CLOV) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.07) by 42.86 percent. This is a 71.43 percent increase over losses of $(0.14) per share from the same period last year. The company reported quarterly sales of $336.96 million which missed the analyst consensus estimate of $382.55 million by 11.92 percent. This is a 7.87 percent increase over sales of $312.38 million the same period last year.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法